symptom-free or steroid-free remission at 52 weeks 52 WEEKS [clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5]

symptom-free or steroid-free remission at 52 weeks 52 WEEKS [clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5]

Tocilizumab, IV, 8 mg/kg, every 2 weeks
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5
Efficacy and Safety of Tocilizumab in Adult's Still Disease [clinicaltrials:NCT01002781]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

symptom-free or steroid-free remission at 52 weeks 52 WEEKS [clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5]

Tocilizumab, IV, 8 mg/kg, every 2 weeks
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Primary outcome [clinicaltrials_vocabulary:primary-outcome]
http://bio2rdf.org/clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5
Bio2RDF identifier
ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5
measure [clinicaltrials_vocabulary:measure]
symptom-free or steroid-free remission at 52 weeks
time frame [clinicaltrials_vocabulary:time-frame]
description
Tocilizumab, IV, 8 mg/kg, every 2 weeks
identifier
clinicaltrials_resource:ed3f8f3d54d3b6b6d6b7c2dd9f80cbb5
title
symptom-free or steroid-free remission at 52 weeks 52 WEEKS
@en
inDataset
type
label
symptom-free or steroid-free r ...... f8f3d54d3b6b6d6b7c2dd9f80cbb5]
@en